hematoporphyrin has been researched along with tamoxifen in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Battaglino, M; Chang, PH; Clark, C; Day, J; Gulliya, KS; Matthews, JL; Pervaiz, S; Preskitt, J; Vanderpool, D | 1 |
| Raub, W | 1 |
3 other study(ies) available for hematoporphyrin and tamoxifen
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Synergy between preactivated photofrin-II and tamoxifen in killing retrofibroma, pseudomyxoma and breast cancer cells.
Topics: Breast Neoplasms; Cell Survival; Dihematoporphyrin Ether; Drug Synergism; Hematoporphyrins; Humans; Light; Male; Neoplasms; Receptors, Estrogen; Retroperitoneal Fibrosis; Tamoxifen; Tumor Cells, Cultured | 1991 |
From the National Institutes of Health.
Topics: Adolescent; Adult; Animals; Blood Glucose; Breast Neoplasms; Diabetes Mellitus, Type 2; Female; Granulomatous Disease, Chronic; Hematoporphyrins; Humans; Insulin-Like Growth Factor I; Interferon-gamma; Middle Aged; National Institutes of Health (U.S.); Neoplasms, Experimental; Photochemotherapy; Tamoxifen; United States | 1991 |